Outcomes in Transplant Recipients Treated with Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

BACKGROUND: Antiviral-resistant or refractory CMV infection is challenging, and salvage therapies, foscarnet and cidofovir, have significant toxicities. Several investigational anti-CMV agents are under development, but more information is needed on outcomes of current treatments, to facilitate clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Avery, Robin K., Arav-Boger, Ravit, Marr, Kieren A., Kraus, Edward, Shoham, Shmuel, Lees, Laura, Trollinger, Brandon, Shah, Pali, Ambinder, Rich, Neofytos, Dionysios, Ostrander, Darin, Forman, Michael, Valsamakis, Alexandra
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030152/
https://ncbi.nlm.nih.gov/pubmed/27495775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados